drug discovery
7 articles tagged with drug discovery
OpenAI introduces MedChemBench to test AI on early drug discovery tasks
MedChemBench evaluates how well AI models interpret molecular structures, reason from experimental evidence, and select compounds in early drug discovery. It is published on OpenAI's site under the title "Can AI help scientists identify promising drug candidates?"
Moonshot AI shifts Kimi focus from coding to science, citing diminishing returns in coding
Moonshot AI is redirecting its Kimi language models toward biology, chemistry and pharma research because it sees diminishing returns in coding. International director Giacomo Ficari said science demands smarter models than law, finance or code. DP Technology is already integrating Kimi K3.1 Pro into its BioMaster research assistant.
Geodesic Intelligence releases NovaAtom-Lite, a biomolecule model it claims tops state-of-the-art systems
Geodesic Intelligence has released NovaAtom-Lite, an AI model that predicts the structures and interactions of biomolecules. Founder Quanquan Gu said the model topped a third-party benchmark in several drug discovery tasks, according to the South China Morning Post.
Google Antigravity gets Cheminformatics Skills; agent runs drug design workflow in an hour, DeepMind says
Google DeepMind has released Cheminformatics Skills for Google Antigravity, pairing a language model agent with RDKit and connectors to ChEMBL and PubChem. In a lung cancer case study, DeepMind says the agent went from literature search to proposed macrocycles with synthetic routes in an hour, versus multiple days for a typical iteration.
Anthropic Builds Physical Biology Lab Where Claude Directs Robots to Run Drug Experiments
Anthropic is setting up a physical biology lab in the San Francisco area where Claude will guide robots through drug experiments with minimal human involvement. The move follows the company's $400 million acquisition of Coefficient Bio and the addition of Novartis CEO Vas Narasimhan to its board.
Anthropic Claims Claude Agents Beat Industry Hit Rates in Autonomous Protein Design Trials
Anthropic published two experiments showing Claude models autonomously running open-source protein design software end-to-end, claiming hit rates of 26.8% against an industry baseline of 10-15%. Independent verification of the results is still pending.
SandboxAQ integrates physics-based drug discovery models into Claude via natural language interface
SandboxAQ has partnered with Anthropic to integrate its physics-based large quantitative models (LQMs) into Claude, making quantum chemistry calculations and molecular dynamics simulations accessible through natural language. The integration eliminates the need for specialized computing infrastructure previously required to run the models.